Search Results 291-300 of 14780 for anti-TNF drugs

1. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   By condition, treatment or drug name. Search ... TNF-α antagonist or vedolizumab or ustekinumab ... Anti-integrin: at least 14 weeks treatment of the ...

2. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

3. Antidepressants: Can they stop working? - Mayo Clinic

   Underlying health problems, such as hypothyroidism, can cause or worsen depression. A new medication. Some medications for unrelated conditions can interfere ...

4. Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment

   The study focused on predicting the response to methotrexate, one of the most common rheumatoid arthritis medications. Applying patient data that included ...

5. Emtricitabine And Tenofovir (Oral Route) Precautions - Mayo Clinic

   These are more common if you are female, very overweight (obese), or have been taking anti-HIV medicines for a long time. Check with your doctor right away ...

6. Anifrolumab-Fnia (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Ustekinumab-Aekn (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Selarsdi. Descriptions. Ustekinumab-aekn injection is used ...

8. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment - Mayo Clinic

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

9. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

10. Genetic testing proves beneficial in prescribing effective blood thinners - Mayo Clinic News Network

    Anti-platelet drugs are given to prevent complications from blood clotting ... drug would benefit from the other anti-platelet medications. The meta ...